OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Sacituzumab Govitecan, Tucatinib, And More!
26 minutes
Posted Apr 24, 2020 at 12:01 am.
Five (5!) new #oncopharm products to discuss. First, sacituzumab govitecan. Then,
tucatinib. Finally,
0:00
26:24
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Five (5!) new #oncopharm products to discuss. First, sacituzumab govitecan. Then, (
9:30
) tucatinib. Finally, (
18:40
) mitomycin gel, pemitgatinib, and selumetinib.
Previous
Journal Club: Unscheduled Hydration in Patients Receiving HEC
Next
Q 6 Pembro, PARP Inhibitors, MonarcHER, Griffin
← See all 273 episodes of OncoPharm